Therapeutic Uses
Anti-Diabetic
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(S)-5-oxopyrrolidine-2-carboxylic acid compound with (1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-
ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (1:1)
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Ertugliflozin L- pyroglutamic acid is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Ertugliflozin L- pyroglutamic acid usage and description
Ertugliflozin L-pyroglutamic acid is a medication that is used to control high blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. This medication works by blocking the absorption of glucose by the kidneys, causing excess glucose to be eliminated through the urine. It is typically prescribed as part of a comprehensive treatment plan that includes diet and exercise.
Ertugliflozin L-pyroglutamic acid is available in tablet form and is taken orally once a day. The dosage and duration of treatment will depend on the individual's medical history, kidney function, and response to treatment. It is important to follow the prescribed dosage and instructions carefully to ensure optimal results and to avoid any potential side effects.
Chemically, Ertugliflozin L-pyroglutamic acid is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is a white to off-white powder with a molecular formula of C22H25ClO7S and a molecular weight of 470.94 g/mol. It is soluble in water and methanol, but insoluble in organic solvents like ethyl acetate and acetonitrile.
In conclusion, Ertugliflozin L-pyroglutamic acid is an effective medication for treating type 2 diabetes. It works by blocking the absorption of glucose by the kidneys, resulting in lower blood sugar levels. It is important to follow the prescribed dosage and instructions carefully to ensure optimal results and to avoid any potential side effects.
